Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$206K Buy
1,398
+46
+3% +$7.48K 0.03% 185
2025
Q4
$264K Buy
1,352
+135
+11% +$32.1K 0.04% 162
2025
Q3
$342K Sell
1,217
-663
-35% -$169K 0.06% 136
2025
Q2
$411K Buy
1,880
+1,410
+300% +$228K 0.08% 120
2025
Q1
$65.7K Buy
+470
New +$76.5K 0.01% 249
2024
Q4
Sell
-8
Closed -$1.36K 436
2024
Q3
$1.36K Buy
+8
New +$1.16K ﹤0.01% 397
2024
Q2
Sell
-268
Closed -$33.7K 441
2024
Q1
$33.7K Hold
268
0.01% 272
2023
Q4
$28.3K Sell
268
-125
-32% -$13.6K 0.01% 269
2023
Q3
$41.6K Hold
393
0.01% 231
2023
Q2
$46.8K Hold
393
0.02% 215
2023
Q1
$36.5K Hold
393
0.01% 229
2022
Q4
$32K Hold
393
0.01% 252
2022
Q3
$24K Buy
+393
New +$28.8K 0.01% 247
2019
Q1
Sell
-202
Closed -$9K 224
2018
Q4
$9K Buy
+202
New +$9.68K 0.01% 190

Other funds holding ORCL

Clearstead Trust's ORCL Position: Q1 2026 in Review

Clearstead Trust increased its Oracle (ORCL) stake by 3.4% in Q1 2026, buying an estimated $7.48K and bringing the position to 1,398 shares worth $206K. The position accounts for 0.03% of the portfolio, ranked #185.

Clearstead Trust first reported a position in ORCL in Q4 2018 and has held it in 14 quarters since. The position peaked at $411K in Q2 2025. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Clearstead Trust held 1,398 shares of Oracle worth $206K as of Q1 2026.
  • Clearstead Trust bought 46 Oracle shares in Q1 2026, an estimated $7.48K.
  • Oracle made up 0.03% of Clearstead Trust's portfolio in Q1 2026, its #185 holding.
  • Clearstead Trust first reported a position in Oracle in Q4 2018 and has held it in 14 quarters since.
  • Clearstead Trust's Oracle position peaked at $411K in Q2 2025.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Clearstead Trust's 13F filing for Q1 2026, filed 6 May 2026.